Zydus launches Rexigo, oral once-a-day pill to treat advanced prostate cancer
Relugolix is reportedly the only oral option of ADT drugs known as gonadotropin releasing hormone (GnRH) analogues
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
relugolix
Myovant Sciences and Accord Healthcare enter into exclusive licence agreement to commercialise…
Myovant to receive an upfront payment of $50 million, is eligible to receive commercial launch, sales-based and other milestones…